ORGANIZACIÓN DEL GRUPO.
12. El terapeuta debería examinar los parámetros de terminación y comienzo para evitar turbulencias y acting-uot posteriores En la situación ideal, los
2.2.1.5. PAPEL DEL LÍDER EN LA TERAPIA DE GRUPO
2.2.1.5.1 ATRIBUTOS DEL LÍDER
(36) (36)
(36) Oya M, Akiyama Y, Okuyama T, et al.: High preoperative plasma D-dimer level is associated with advanced tumor stage and short survival after curative resection in patients with colorectal cancer.
Jpn J Clin Oncol
2001; 388-400(37) (37) (37)
(37) Callander NS, Varki N, Rao LV: Immunhistochemical identification of tissue factor in solid tumors.
Cancer
1992; 1194-1201(38) (38) (38)
(38) Nakasaki T, Wada H, Shigemori C, et al.: Expression of tissue factor and vascular endothelial growth factor is associated with angiogenesis in colorectal cancer.
Am J
Hematol
2002; 247-254(39 (39(39
(39) ) ) ) Boccaccio C, Sabatino G, Medico E, et al.: The MET oncogene drives a genetic programme linking cancer to haemostasis.
Nature
2005; 396-400(40) (40) (40)
(40) Rauch U, Antoniak S: Tissue factor-positive microparticles in blood associated with coagulopathy in cancer.
J Thromb Haemost
2007; 9-10(41) (41) (41)
(41) Amirkhosravi A, Meyer T, Sackel D, Desai H, Biddinger R, Amaya M, Francis JL: Platelet microparticles upregulate TF and VEGF in endothelial and melanoma cells in a CD40 ligand-dependent manner: possible role in angiogenesis and metastasis.
Blood
2002; 100(11)100(11)100(11)
100(11): 63b # 3721 (42)
(42) (42)
(42) Belting M, Dorrell M, Sandgren S, Ahamad J, Dorfleutner A, Carmeliet P, Mueller B, Friedlander M, Ruf W: Tissue factor signalling in angiogenesis.
Blood
2003; 102 (11)102 (11)102 (11)102 (11): 13a #33(43) (43) (43)
(43) Taraboletti G, Roberts D, Liotta LA, Giavazzi R: Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory.
J Cell
Biol
1990; 111111111111: 765-772(44 (44(44
(44)))) Mancuso P: Resting and activated endothelial cells are increased in the peripheral blood of cancer patients.
Blood
2001; Vol 97Vol 97Vol 97Vol 97, No.11: 3658-3661(45 (45(45
(45)))) Beerepoot LV: Increased levels of viable circulating endothelial cells are an indicator of progressive disease in cancer patients.
Annals of Oncology
2004; 15151515: 139-145(46) (46)(46)
(46) Manusco P, Calleri A, Cassi C, Gobbi A, Capillo M, Pruneri G, Martinelli G, Bertolini F: Circulating endothelial cells as anovel marker of angiogenesis.
Adv Exp Med Biol
2003; 522522522
522: 83-97 (47) (47) (47)
(47) Kim HK, Song KS, Chung JH, Lee KR, Lee NS: Platelet microparticles induce angiogenesis in vitro.
Br J Haematol
2004 Feb; 124 (3)124 (3)124 (3)124 (3): 376-384(48 (48(48
(48)))) Janowska-Wieczorek A, Kijowski J, Marquez LA, Ratajczak J, Ratajczak MZ: Microvesicles derived from activated platelets: an under-appreciated modulator of the metastatic potential of tumor cells.
Blood
2003; 102 (11)102 (11)102 (11): 73b #3998 102 (11)((((49494949)))) Manual Mammakarzinome – Empfehlungen zur Diagnostik, Therapie und Nachsorge; Bandherausgeber: PD Dr. med. Wolfgang Janni, 11. überarbeitete Auflage 2007; Herausgeber: Tumorzentrum München
(50) (50)(50)
(50) Mesri M, Altieri DC: Endothelial cell activation by leukocyte microparticles. J Immunol 1998; 161:161:161:161: 4382-4387
(51 (51(51
(51)))) Rauch U, Bondermann D, Bohrmann B, Badimon JJ, Himber J, Riederer MA, Nemerson Y: Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor.
Blood
2000; 96 (1):96 (1):96 (1):96 (1): 170-175(52 (52(52
(52)))) Myers DD, Hawley AE, Farris DM, Wrobleski SK, Thanaporn P, Schaub RG, Wagner DD, Kumar A, Wakefield TW: P-selectin and leukocyte microparticles are associated wirh venous thrombogenesis.
J Vasc Surg
2003; 38 (5): 38 (5): 38 (5): 38 (5): 1075-1089(53 (53(53
(53)))) Furie B, Furie BC: Cancer-associated thrombosis. J BCMD 2005; 36:36:36: 177-181 36: (54
(54(54
(54)))) Gross P, Furie BC, Merrill-Skoloff G, Chou J, Furie B: Leukocyte- versus microparticle-mediated tissue factor transfer during arteriolar thrombus development. J Leuk Biol 2005; 115:115:115:115: 3355-3362
(55 (55(55
(55)))) Hrachovinova II, Cambien B, Hafezi-Moghadam A, Kappelmayer J, Camphausen RT, Widom A, Xia L, Kazazian HH, Schaub RG, McEver RP, Wagner DD: Interaction of P- selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A. Nat Med 2003; 9:9:9:9: 1020-1025
(56 (56(56
(56)))) Goon, PKY, Boos CJ, Stonelake PS, Lip GYH: Circulating endothelial cells in malignant disease. Future Oncol 2005; 1 (6):1 (6):1 (6):1 (6): 813-820
(57 (57(57
(57)))) Goon PKY, Lip GYH, Boos CJ, Stonelake PS, Blann AD: Circulating endothelial cells, endothelial progenitor cells, and endothelial microparticles in cancer. Neoplasia 2006; 8(2):
8(2):8(2):
8(2): 79-88 (58
(58(58
(58)))) Manusco P, Burlini A, Pruneri G, Goldhirsch A, Martinelli G, Bertolini F: Resting and activated endothelial cells are increased in the peripheral blood of cancer patients. Blood 2001; 97(11):97(11):97(11): 3658-3661 97(11):
(59 (59(59
(59)))) Bertolini F, Paul S, Manusco P, Monestiroli S, Gobbi A, Shaked Y, Kerbel RS: Maximum tolerable dose and low-dose metronomic chemotherapy have opposite effects on the mobilization and viability of circulating endothelial progenitor cells. Cancer Res 2003; 63:63:63: 4342-4346 63:
(60 (60(60
(60)))) Rohsig LM, Damin DC, Stefani SD, Castro CG Jr, Roisenberg I, Schwartsmann G: von Willebrand factor antigen levels in plasma of patients with malignant breast disease.
Braz
J Med Biol Re
2001; 34: 34: 34: 1125-1129 34:(61 (61(61
(61) ) ) ) Blann AD, Gurney D, Wadley M, Bareford D, Stonelake P, Lip GY: Increased soluble P-selectin in patients with haematological and breast cancer: a comparison with with fibrinogen, plasminogen activator inhibitor and von Willebrand factor.
Blood Coagul
Fibrinolysis
2001; 12 (1): 12 (1): 12 (1): 12 (1): 43-50(62 (62(62
(62) ) ) ) Blann AD, Baildam AD, Howell A, Miller JP: Tamoxifen increases von Willebrand factor in women who underwent breast cancer surgery.
Thromb Haemost
2001; 85 (5): 85 (5): 85 (5): 85 (5): 941-942(63 (63(63
(63)))) Del Cone I, Bharwani LD, Dietzen DJ, Pendurthi U, Thiagarajan P, Lopez JA: Microvesicle-associated tissue factor and Trousseau’s syndrome. Thromb Haemost 2006; 5:5:5:5: 70-74
(64 (64(64
(64) ) ) ) van der Zee PM, Biro E, Ko Y, de Winter RJ, Hack CE, Sturk A, et al.: P-selectin and CD63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myocardial infarction.
Clin Chem
2006.(65 (65(65
(65) ) ) ) Michelson AD, Barnard MR, Hechtman HB, MacGregor H, Connolly RJ, Loscalzo J, et al.: In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function.